Loading organizations...
§ Private Profile · Bordeaux, Aquitaine, France
AI-powered diagnostic tools for cardiac imaging. HeartFocus software guides healthcare professionals for early heart disease detection.
Based in Bordeaux, France, DESKi develops AI-powered diagnostic software that provides real-time guidance for cardiac ultrasound scans to assist medical professionals. The company's flagship FDA-approved software product, HeartFocus, utilizes proprietary algorithms trained on over 10 million data points to enable healthcare workers to perform accurate echocardiograms with minimal prior specialized training. Operating within the broader healthtech sector, the firm sells its software and SDK integrations directly to primary care facilities, rural clinics, and point-of-care ultrasound providers, recently partnering with Inteleos to launch an AI cardiac certification program. To support its commercial expansion into the United States and other global markets, the enterprise secured a €5.2 million seed funding round in 2025 from institutional investors including Racine2, BNP Paribas Développement, and Épopée Gestion. DESKi was officially founded in 2016 by Bertrand Moal and Olivier Moal.
DESKi has raised $6.0M across 1 funding round.
DESKi has raised $6.0M in total across 1 funding round.
DESKi has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in June 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 18, 2025 | $6M Seed | LÉA Zaslavsky | Baptiste Hamel, Sophie Pierrin Lepinard, Camille LE Roux Larsabal, Geoffroy Vincent, Hortense Mellinger | Announced |
DESKi has raised $6.0M in total across 1 funding round.
DESKi's investors include Léa Zaslavsky, Baptiste Hamel, Sophie PIERRIN LEPINARD, Camille Le Roux Larsabal, Geoffroy VINCENT, Hortense Mellinger.